Mechanisms of disease: Genetic defects of intracellular-membrane transport

New England Journal of Medicine

Volumn 343, Issue 15, 2000, Pages 1095-1104

  Olkkonen, V M ^a   Ikonen, E ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING PROTEIN; MYOSIN; N ACETYLGLUCOSAMINE 1 PHOSPHOTRANSFERASE; RAB PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; PROTEIN;

BLOOD CLOTTING FACTOR 5 DEFICIENCY; CHEDIAK HIGASHI SYNDROME; GENETIC DISORDER; HEMOPHILIA A; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR TRANSPORT; LOWE SYNDROME; MEMBRANE TRANSPORT; MENTAL RETARDATION MALFORMATION SYNDROME; MUCOLIPIDOSIS; OCULAR ALBINISM; PRIORITY JOURNAL; REVIEW; ACTIVE TRANSPORT; CELL ORGANELLE; COATED VESICLE; GENETICS; INTRACELLULAR MEMBRANE; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

BIOLOGICAL TRANSPORT, ACTIVE; COATED VESICLES; CYTOSKELETAL PROTEINS; GENETIC DISEASES, INBORN; HUMANS; INTRACELLULAR MEMBRANES; LIPID METABOLISM; ORGANELLES; PROTEINS;

EID: 0034641833     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200010123431507     Document Type: Review

References (72)

1. Folding of secretory and membrane proteins
2. The β3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness
3. Identification of the homologous beige and Chediak-Higashi syndrome genes
4. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice
5. Novel myosin heavy chain encoded by murine dilute coat color locus
6. A type VII myosin encoded by the mouse deafness gene shaker-1
7. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline
8. The trans-Golgi network: A late secretory sorting station
9. Disease models provide insights into post-Golgi protein trafficking, localization and processing
10. Membrane transport in the endocytic pathway
11. Endocytosis and molecular sorting
12. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells
13. COPII and secretory cargo capture into transport vesicles
14. Mechanisms of protein sorting and coat assembly: Insights from the clathrin-coated vesicle pathway
15. Mechanisms of vesicle formation: Insights from the COP system
16. Lipid regulators of membrane traffic through the Golgi complex
17. Mechanisms of cell polarity: Sorting and transport in epithelial cells
18. Protein and lipid sorting from the trans-Golgi network to the plasma membrane in polarized cells
19. Functional rafts in cell membranes
20. Cytoskeletal proteins and Golgi dynamics
21. Unconventional myosins in cell movement, membrane traffic, and signal transduction
22. Membrane tethering in intracellular transport
23. SNAREpins: Minimal machinery for membrane fusion
24. Role of Rab GTPases in membrane traffic
25. The diversity of Rab proteins in vesicle transport
26. Trafficking of lysosomal enzymes in normal and disease states
27. The biogenesis of lysosomes
28. Molecular recognition and targeting of lysosomal proteins
29. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII
30. The recyding of ERGIC-53 in the early secretory pathway: ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII
31. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins
32. Pigment, platelets, and Hermansky-Pudlak in human and mouse
33. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytophsmic organelles
34. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β3A subunit of the AP-3 adaptor
35. Genetic defects in Chediak-Higashi syndrome and the beige mouse
36. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lyric granule exocytosis
37. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome
38. The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein
39. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: The Chediak-Higashi syndrome
40. Partial albinism with immunodeficiency (Griscelli syndrome)
41. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene
42. Visualization of melanosome dynamics within wild-type and dilute melanocytes suggests a paradigm for myosin V function in vivo
43. Myosin Va movements in normal and dilute-lethal axons provide support for a dual filament motor complex
44. Defective myosin VIIA gene responsible for Usher syndrome type 1B
45. Human Usher 1B/mouse shaker-1: The retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells
46. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B
47. Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells
48. Cloning of a gene that is rearranged in patients with choroideraemia
49. Isolation of a candidate gene for choroideremia
50. Purification of component A of Rab geranylgeranyl transferase: Possible identity with the choroideremia gene product
51. Retinal degeneration in choroideremia: Deficiency of Rab geranlygeranyl transferase
52. REP-2, a Rab escort protein encoded by the Choroideremia-like gene
53. Deficient geranylgeranylation of Ram/Rab27 in choroideremia
54. Mutations in GDI1 are responsible for X-linked non-specific mental retardation
55. Rab GDP dissociation inhibitor: Putting Rab GTPases in the right place
56. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase
57. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase
58. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus
59. Phosphoinositides in membrane traffic
60. Intracellular cholesterol transport
61. Niemann-Pick Cl disease gene: Homology to mediators of cholesterol homeostasis
62. The Niemann-Pick Cl protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo
63. Niemann-Pick Cl protein: Obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization
64. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport
65. Mobilization of late-endosomal cholesterol is inhibited by Rab guanine nucleofide dissociation inhibitor
66. The ABCs of cholesterol efflux
67. The Tangler disease gene product ABCl controls the cellular apolipoprotein-mediated lipid removal pathway
68. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration
69. Decreased reverse cholesterol transport from Tangler disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux
70. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking: Location! location! location!
71. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance
72. Human pathogen subversion of antigen presentation